J 995
Latest Information Update: 16 Jan 2008
Price :
$50 *
At a glance
- Originator Jenapharm
- Class Hormonal replacements; Small molecules; Sulfonamides
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome; Pregnancy
Most Recent Events
- 22 Jan 1999 Phase-I clinical trials for Menopausal syndrome in Germany (Unknown route)
- 22 Jan 1999 Phase-I clinical trials for Pregnancy (Prevention) in Germany (Unknown route)